<Version>
  <xmlSource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Quality Measures Clearinghouse (NQMC).</xmlSource>
  <Section SecID="298" OrdBy="100" Name="General">
    <Field FieldID="11" OrdBy="105" ID="299" Name="Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Advanced chronic kidney disease (CKD): percent of patients prescribed vitamin D&lt;sub&gt;2&lt;/sub&gt;.&lt;/div&gt;" />
    </Field>
    <Field FieldID="1" OrdBy="110" ID="300" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Renal Physicians Association. Appropriate patient preparation for renal replacement therapy. Rockville (MD): Renal Physicians Association; 2002 Oct 1. 78 p.&amp;nbsp;(Clinical Practice Guideline; no. 3).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
  </Section>
  <Section SecID="301" OrdBy="200" Name="Measure Domain">
    <Field FieldID="25" OrdBy="205" ID="302" Name="Primary Measure Domain" Type="picklist-one">
      <FieldValue Value="Process&lt;div class=&quot;content_special_handling&quot;&gt;&lt;p&gt;The validity of measures depends on how they are built. By examining the key building blocks of a measure, you can assess its validity for your purpose. For more information, visit the &lt;a href=&quot;/selecting-and-using/validity.aspx&quot;&gt;Measure Validity&lt;/a&gt; page.&lt;p/&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="26" OrdBy="210" ID="303" Name="Secondary Measure Domain" Type="picklist-many">
      <FieldValue Value="Does not apply to this measure" />
    </Field>
  </Section>
  <Section SecID="304" OrdBy="300" Name="Brief Abstract">
    <Field FieldID="34" OrdBy="305" ID="305" Name="Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure assesses the percent of patients prescribed vitamin D&lt;sub&gt;2&lt;/sub&gt; among patients with advanced chronic kidney disease (CKD) and immunoreactive parathyroid hormone (iPTH) greater than 100 pg/mL (or greater than 1.5 times the upper limit of normal for each assay used) and vitamin D level less than 30 ng/mL.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="21" OrdBy="310" ID="306" Name="Rationale" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Renal osteodystrophy is a complex and multifaceted disease process that begins early in the course of chronic kidney disease (CKD) and is a major, long-term complication associated with high rates of morbidity. The metabolic and skeletal derangements associated with renal osteodystrophy are not easily reversed and, therefore, early interventions are crucial.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Serum levels of 1,25(OH)&lt;sub&gt;2&lt;/sub&gt;D correlate with 25(OH)D in CKD stage 3 and 4, indicating that the generation of 1,25(OH)&lt;sub&gt;2&lt;/sub&gt;D in CKD patients depends on supply of 25(OH)D. Patients with CKD are more likely than non-CKD patients to have 25(OH)D levels less than 30 ng/mL. Levels of 25(OH) vitamin D less than 30 ng/mL but within the normal range have been associated with elevated immunoreactive parathyroid hormone (iPTH) levels in the elderly, and levels less than 15 ng/mL have been associated with a greater severity of secondary hyperparathyroidism (HPTH) in end-stage renal disease (ESRD) patients. Therapy may reduce fracture risk in the elderly.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="22" OrdBy="315" ID="307" Name="Primary Clinical Component" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Advanced chronic kidney disease; renal osteodystrophy; immunoreactive parathyroid hormone; 25(OH) vitamin D; vitamin D insufficiency&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="23" OrdBy="320" ID="308" Name="Denominator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The number of adult patients with advanced chronic kidney disease (CKD), not currently receiving renal replacement therapy, with immunoreactive parathyroid hormone (iPTH) greater than 100 pg/mL (or greater than 1.5 times the upper limit of normal for each assay used) and vitamin D level less than 30 ng/mL&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="24" OrdBy="325" ID="309" Name="Numerator Description" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The number of patients from the denominator prescribed vitamin D&lt;sub&gt;2&lt;/sub&gt;&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="310" OrdBy="400" Name="Evidence Supporting the Measure">
    <Field FieldID="27" OrdBy="405" ID="311" Name="Evidence Supporting the Criterion of Quality" Type="picklist-choice">
      <FieldValue Value="A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence" />
      <FieldValue Value="A formal consensus procedure involving experts in relevant clinical, methodological, and organizational sciences" />
      <FieldValue Value="A systematic review of the clinical literature" />
    </Field>
  </Section>
  <Section SecID="315" OrdBy="500" Name="Evidence Supporting Need for the Measure">
    <Field FieldID="28" OrdBy="505" ID="316" Name="Need for the Measure" Type="picklist-choice">
      <FieldValue Value="Unspecified" />
    </Field>
  </Section>
  <Section SecID="318" OrdBy="600" Name="State of Use of the Measure">
    <Field FieldID="29" OrdBy="605" ID="319" Name="State of Use" Type="picklist-one">
      <FieldValue Value="Pilot testing" />
    </Field>
    <Field FieldID="30" OrdBy="610" ID="320" Name="Current Use" Type="picklist-choice">
      <FieldValue Value="Internal quality improvement" />
    </Field>
  </Section>
  <Section SecID="321" OrdBy="700" Name="Application of Measure in its Current Use">
    <Field FieldID="31" OrdBy="705" ID="322" Name="Care Setting" Type="picklist-choice">
      <FieldValue Value="Ambulatory Care" />
      <FieldValue Value="Physician Group Practices/Clinics" />
    </Field>
    <Field FieldID="32" OrdBy="710" ID="323" Name="Professionals Responsible for Health Care" Type="picklist-choice">
      <FieldValue Value="Physicians" />
    </Field>
    <Field FieldID="33" OrdBy="715" ID="324" Name="Lowest Level of Health Care Delivery Addressed" Type="picklist-one">
      <FieldValue Value="Individual Clinicians" />
    </Field>
    <Field FieldID="41" OrdBy="720" ID="325" Name="Target Population Age" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Age greater than or equal to 18 years&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="42" OrdBy="725" ID="326" Name="Target Population Gender" Type="picklist-one">
      <FieldValue Value="Either male or female" />
    </Field>
    <Field FieldID="44" OrdBy="730" ID="327" Name="Stratification by Vulnerable Populations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="328" OrdBy="800" Name="Characteristics of the Primary Clinical Component">
    <Field FieldID="45" OrdBy="805" ID="329" Name="Incidence/Prevalence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="46" OrdBy="815" ID="331" Name="Association with Vulnerable Populations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="47" OrdBy="825" ID="333" Name="Burden of Illness" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Levels of 25(OH) vitamin D less than 30 ng/mL but within the normal range have been associated with elevated immunoreactive parathyroid hormone (iPTH) levels in the elderly, and levels less than 15 ng/mL have been associated with a greater severity of secondary hyperparathyroidism (HPTH) in end-stage renal disease (ESRD) patients.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="4" OrdBy="830" ID="334" Name="Evidence for Burden of Illness" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Moriniere P, Garabedian M, Eastwood J, Fournier A. Is low plasma 25 (OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?. Kidney Int. 1999 Jun;55(6):2169-77. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10354266&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="48" OrdBy="835" ID="335" Name="Utilization" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="49" OrdBy="845" ID="337" Name="Costs" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="339" OrdBy="900" Name="Institute of Medicine (IOM) Healthcare Quality Report Categories">
    <Field FieldID="163" OrdBy="905" ID="340" Name="IOM Care Need" Type="picklist-choice">
      <FieldValue Value="Living with Illness" />
    </Field>
    <Field FieldID="164" OrdBy="910" ID="341" Name="IOM Domain" Type="picklist-choice">
      <FieldValue Value="Effectiveness" />
    </Field>
  </Section>
  <Section SecID="342" OrdBy="1000" Name="Data Collection for the Measure">
    <Field FieldID="52" OrdBy="1005" ID="343" Name="Case Finding" Type="picklist-one">
      <FieldValue Value="Users of care only" />
    </Field>
    <Field FieldID="53" OrdBy="1010" ID="344" Name="Description of Case Finding" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Adult patients 18 years and older with advanced chronic kidney disease (CKD) and immunoreactive parathyroid hormone (iPTH) greater than 100 pg/mL (or greater than 1.5 times the upper limit of normal for each assay used) and vitamin D level less than 30 ng/mL&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="55" OrdBy="1020" ID="346" Name="Denominator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br&gt;&#xD;&#xA;Adult patients age 18 years and older with chronic kidney disease stage 4 or 5 (glomerular filtration rate [GFR] less than or equal to 30 mL/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;), not currently receiving renal replacement therapy, with immunoreactive parathyroid hormone (iPTH) greater than 100 pg/mL (or greater than 1.5 times the upper limit of normal for each assay used) and vitamin D level less than 30 ng/mL&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br&gt;&#xD;&#xA;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="56" OrdBy="1025" ID="347" Name="Relationship of Denominator to Numerator" Type="picklist-one">
      <FieldValue Value="All cases in the denominator are equally eligible to appear in the numerator" />
    </Field>
    <Field FieldID="57" OrdBy="1030" ID="348" Name="Denominator (Index) Event" Type="picklist-choice">
      <FieldValue Value="Clinical Condition" />
    </Field>
    <Field FieldID="58" OrdBy="1035" ID="349" Name="Denominator Time Window" Type="picklist-one">
      <FieldValue Value="Time window precedes index event " />
    </Field>
    <Field FieldID="59" OrdBy="1040" ID="350" Name="Numerator Inclusions/Exclusions" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br&gt;&#xD;&#xA;The number of patients from the denominator prescribed vitamin D&lt;sub&gt;2&lt;/sub&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;sup&gt;*&lt;/sup&gt;Prescribed vitamin D dosage is vitamin D&lt;sub&gt;2&lt;/sub&gt; 50,000 units orally every month for six months.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br&gt;&#xD;&#xA;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="60" OrdBy="1045" ID="351" Name="Measure Results Under Control of Health Care Professionals, Organizations and/or Policymakers" Type="picklist-one">
      <FieldValue Value="The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies." />
    </Field>
    <Field FieldID="61" OrdBy="1050" ID="352" Name="Numerator Time Window" Type="picklist-one">
      <FieldValue Value="Episode of care" />
    </Field>
    <Field FieldID="62" OrdBy="1055" ID="353" Name="Data Source" Type="picklist-choice">
      <FieldValue Value="Administrative data " />
      <FieldValue Value="Laboratory data" />
      <FieldValue Value="Medical record" />
      <FieldValue Value="Pharmacy data" />
    </Field>
    <Field FieldID="63" OrdBy="1060" ID="354" Name="Level of Determination of Quality" Type="picklist-one">
      <FieldValue Value="Individual Case" />
    </Field>
    <Field FieldID="66" OrdBy="1075" ID="357" Name="Pre-existing Instrument Used" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="358" OrdBy="1100" Name="Computation of the Measure">
    <Field FieldID="67" OrdBy="1105" ID="359" Name="Scoring" Type="picklist-one">
      <FieldValue Value="Rate" />
    </Field>
    <Field FieldID="68" OrdBy="1110" ID="360" Name="Interpretation of Score" Type="picklist-one">
      <FieldValue Value="Better quality is associated with a higher score" />
    </Field>
    <Field FieldID="90" OrdBy="1115" ID="361" Name="Allowance for Patient Factors" Type="picklist-choice">
      <FieldValue Value="Unspecified" />
    </Field>
    <Field FieldID="70" OrdBy="1125" ID="363" Name="Standard of Comparison" Type="picklist-choice">
      <FieldValue Value="Internal time comparison" />
    </Field>
  </Section>
  <Section SecID="366" OrdBy="1200" Name="Evaluation of Measure Properties">
    <Field FieldID="72" OrdBy="1205" ID="367" Name="Extent of Measure Testing" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="369" OrdBy="1300" Name="Identifying Information">
    <Field FieldID="73" OrdBy="1301" ID="473" Name="Original Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Number of patients prescribed vitamin D&lt;sub&gt;2&lt;/sub&gt; / number of patients with advanced CKD and iPTH greater than 100 pg/mL (or greater than 1.5 times the upper limit of normal for each assay used) and vitamin D level less than 30 ng/mL.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="74" OrdBy="1303" ID="474" Name="Measure Collection Name" Type="text">
      <FieldValue Value="Renal Physicians Association Clinical Performance Measures on Appropriate Patient Preparation for Renal Replacement Therapy" />
    </Field>
    <Field FieldID="75" OrdBy="1305" ID="475" Name="Measure Set Name" Type="text">
      <FieldValue Value="Clinical Performance Measures for Bone Disease Recommendations" />
    </Field>
    <Field FieldID="16" OrdBy="1310" ID="371" Name="Submitter" Type="orglist">
      <FieldValue Value="Renal Physicians Association - Medical Specialty Society" />
    </Field>
    <Field FieldID="17" OrdBy="1315" ID="372" Name="Developer" Type="orglist-p">
      <FieldValue Value="Renal Physicians Association - Medical Specialty Society" />
    </Field>
    <Field FieldID="79" OrdBy="1320" ID="373" Name="Funding Source(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Ortho Biotech Products, LP&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="80" OrdBy="1325" ID="374" Name="Composition of the Group that Developed the Measure" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;W. Kline Bolton, MD, Working Group Chair, University of Virginia School of Medicine, Charlottesville, VA; William F. Owen, Jr., MD, President, RPA, Duke University School of Medicine Durham, NC; Baxter Healthcare Corp., McGaw Park, IL; Dale Singer, MHA, Executive Director, RPA.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Content Experts&lt;/em&gt;: Jack Coburn, MD, UCLA School of Medicine, West Los Angeles V.A. Healthcare Center, West Los Angeles, CA; William Haley, MD, Mayo Clinic, Jacksonville, FL; Annamaria Kausz, MD, New England Medical Center, Boston, MA; Adeera Levin, MD, St. Paul's Hospital, Vancouver, BC; William Mitch, MD, University of Texas Medical Branch, Galveston, TX; Patricia Painter, PhD, University of California, San Francisco, CA; Michael Rocco, MD, MSCE, Wake Forest University School of Medicine, Winston-Salem, NC.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Association Representatives&lt;/em&gt;: Carolyn Atkins, RN, BS, CCTC, National Kidney Foundation, Medical City Dallas Hospital, Dallas, TX; Shelley Clark, RN, National Renal Administrators Association, FMC North Roanoke Dialysis, Roanoke, VA; Paul Eggers, PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD; Lori Fedje, RD, LD, NKF Council on Renal Nutrition, Pacific Northwest Renal Services, Portland, OR; Richard Goldman, MD, Renal Physicians Association, Renal Medicine Associates, Emeritus Albuquerque, NM; Joel Greer, PhD, Centers for Medicare and Medicaid Services, Baltimore, MD; Richard Lafayette, MD, American Society of Nephrology, Stanford University School of Medicine, Stanford, CA; Eugene Z. Oddone, MD, American College of Physicians - American Society of Internal Medicine, Durham VA Medical Center, Durham, NC; Victoria Norwood, MD, American Society of Pediatric Nephrology, University of Virginia, Charlottesville, VA; Paul M. Palevsky, MD, Forum of ESRD Networks, University of Pittsburgh School of Medicine, VA Pittsburgh Health Care System, Pittsburgh, PA; Sandy Peckens, MSW, NKF Council of Nephrology Social Workers, Merrimack Valley Nephrology, Methuen, MA; Venkateswara Rao, MD, American Society of Transplantation, Hennepin County Medical Center, Minneapolis, MN; Charlotte Thomas Hawkins, PhD, RN, CNN, American Nephrology Nurses Association, Rutgers, The State University of New Jersey, Burlington, NJ; Joseph White, American Association of Kidney Patients.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Methodologists&lt;/em&gt;: David B. Matchar, MD, FACP, Director, Duke Center for Clinical Health Policy Research and Co-Director, Duke Evidence-based Practice Center, Durham, NC; Douglas C. McCrory, MD, MHS, Co-Director Duke Evidence-based Practice Center, Durham, NC; Joseph A. Coladonato, MD, Duke Institute of Renal Outcomes Research &amp; Health Policy, Durham, NC; Preston S. Klassen, MD, MHS, Duke Institute of Renal Outcomes Research &amp; Health Policy, Durham, NC; Meenal B. Patwardhan, MD, MHSA, Duke Center for Clinical Health Policy Research and Duke Evidence-based Practice Center, Durham, NC; Donal N. Reddan, MD, MHS, Duke Institute of Renal Outcomes Research &amp; Health Policy, Durham, NC; Olivier T. Rutschmann, MD, MPH, Duke Center for Clinical Health Policy Research, Durham, NC; William S. Yancy, Jr., MD, MHS, Duke University Medical Center, Durham, NC.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Medical Editor&lt;/em&gt;: Rebecca N. Gray, DPhil, Duke Evidence-based Practice Center, Durham, NC.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Project Manager and Editor&lt;/em&gt;: Emily G. Shurr, MA, Duke Evidence-based Practice Center, Durham, NC.&lt;/p&gt;&#xD;&#xA;&lt;/div&gt;" />
    </Field>
    <Field FieldID="81" OrdBy="1330" ID="375" Name="Financial Disclosures/Other Potential Conflicts of Interest" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;There were none disclosed.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="19" OrdBy="1345" ID="378" Name="Adaptation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Measure was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="85" OrdBy="1355" ID="380" Name="Release Date" Type="date">
      <FieldValue Value="2002 Oct" />
    </Field>
    <Field FieldID="20" OrdBy="1365" ID="382" Name="Measure Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the measure.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="1" OrdBy="1366" ID="300" Name="Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Renal Physicians Association. Appropriate patient preparation for renal replacement therapy. Rockville (MD): Renal Physicians Association; 2002 Oct 1. 78 p.&amp;nbsp;(Clinical Practice Guideline; no. 3).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="14" OrdBy="1370" ID="383" Name="Measure Availability" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The individual measure, &quot;Number of patients prescribed vitamin D&lt;sub&gt;2&lt;/sub&gt; / number of patients with advanced CKD and iPTH greater than 100 pg/mL (or greater than 1.5 times the upper limit of normal for each assay used) and vitamin D level less than 30 ng/mL,&quot; is published in &quot;Renal Physicians Association Clinical Practice Guideline #3: Appropriate Patient Preparation for Renal Replacement Therapy.&quot;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;For more information, contact RPA at 1700 Rockville Pike, Suite 220, Rockville, MD 20852; phone: 301-468-3515; fax: 301-468-3511; Web site: &lt;a href=&quot;http://www.renalmd.org/&quot; title=&quot;RPA Homepage&quot; target=&quot;_blank&quot;&gt;www.renalmd.org&lt;/a&gt;; e-mail: &lt;A href=&quot;mailto:rpa@renalmd.org&quot;&gt;rpa@renalmd.org&lt;/A&gt;.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="87" OrdBy="1380" ID="385" Name="NQMC Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary was completed by ECRI on May 23, 2003.  The information was verified by the Renal Physicians Association on June 17, 2003.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="88" OrdBy="1385" ID="386" Name="Copyright Statement" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;For more information, contact RPA at 1700 Rockville Pike, Suite 220, Rockville, MD 20852; phone: 301-468-3515; fax: 301-468-3511; Web site: &lt;a href=&quot;http://www.renalmd.org/&quot; title=&quot;RPA Homepage&quot; target=&quot;_blank&quot;&gt;www.renalmd.org&lt;/a&gt;; e-mail: &lt;A href=&quot;mailto:rpa@renalmd.org&quot;&gt;rpa@renalmd.org&lt;/A&gt;.&lt;/p&gt; &lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="99999" OrdBy="99999" Name="Disclaimer">
    <Field FieldID="99999" OrdBy="99999" ID="99999" Name="NQMC Disclaimer" Type="text">
      <FieldValue Value="&lt;p&gt;The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the &lt;a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;&gt;NQMC Inclusion Criteria&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding measure content are directed to contact the measure developer.&lt;/p&gt;" />
    </Field>
  </Section>
</Version>